“…This study was based on the adaptation to leukemia cells [11,12] of the CRA assay developed in our laboratory [2] and successfully applied [3,5,7,13] for the quantification in vitro of the stem cell potential of normal hematopoietic cell populations. The CRA assay, in combination with incubation under severe hypoxia as a selection procedure, showed that the MEL cell population includes highly hypoxia-sensitive CFC as well as their hypoxia-resistant, CRC-type progenitors.…”